SCHEDULE 13D/AFiled Apr 1, 8:00 PM ET

Tempest Therapeutics, Inc. SCHEDULE 13D/A

Versant Venture Capital VI, L.P.

Summary not available

This filing does not have a generated research summary. You can still open the original filing and its exhibits.